These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18165611)

  • 1. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation.
    Kieta DR; McCammon AT; Holman WL; Nielsen VG
    Anesth Analg; 2003 Apr; 96(4):956-958. PubMed ID: 12651640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
    Hursting MJ; Verme-Gibboney CN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
    Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
    John TE; Hallisey RK
    Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 8. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
    Naganuma T; Mitomo S; Kin N; Nakamura S
    A A Case Rep; 2016 Oct; 7(7):158-60. PubMed ID: 27513970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.
    Hallman SE; Hebbar L; Robison J; Uber WE
    Anesth Analg; 2005 Apr; 100(4):946-948. PubMed ID: 15781503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
    Ekbatani A; Asaro LR; Malinow AM
    Int J Obstet Anesth; 2010 Jan; 19(1):82-7. PubMed ID: 19625181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
    LaMonte MP; Brown PM; Hursting MJ
    Crit Care Med; 2004 Apr; 32(4):976-80. PubMed ID: 15071388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.
    Raaz U; Maegdefessel L; Buerke M; Janusch M; Werdan K; Schlitt A
    Thromb Res; 2009 Jun; 124(2):242-3. PubMed ID: 19019411
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacotherapy: argatroban--alternative to heparin in case of heparin-induced thrombocytopenia type II (HIT II)].
    Schönfeld H; Hein OV
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jun; 41(6):376-7. PubMed ID: 16804787
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.